Our study demonstrates that HMGB1 can contribute to the pathogenesis of psoriasis by regulating Th17 cell differentiation through the HMGB1‐TLR4‐IL‐23‐RORγt pathway, then promote IL‐17A production and aggravate inflammation process. Here, HMGB1 is linked to psoriasis.